The cardioprotective effect of sildenafil is mediated by the activation of malate dehydrogenase and an increase in the malate-aspartate shuttle in cardiomyocytes-Reference-Cited by-同舟云学术

The cardioprotective effect of sildenafil is mediated by the activation of malate dehydrogenase and an increase in the malate-aspartate shuttle in cardiomyocytes

Published:2017-03 Issue: Volume:127 Page:60-70
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Gevi Federica,Campolo Federica,Naro Fabio,Zolla Lello

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference39 articles.

1. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction;Boolell;Int. J. Impot.,1996

2. The role of phosphodiesterase-5 inhibitors in prostatic inflammation: a review;Peixoto;J. Inflamm.,2015

3. Sildenafil and Cardioprotection;Kukreja;Curr. Pharm. Des.,2013

4. Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics;Tsai;Pharmacol. Ther.,2009

5. Cardioprotection with phosphodiesterase-5 inhibition-a novel preconditioning strategy;Kukreja;J. Mol. Cell. Cardiol.,2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. α-Ketoglutarate improves cardiac insufficiency through NAD+-SIRT1 signaling-mediated mitophagy and ferroptosis in pressure overload-induced mice;Molecular Medicine;2024-01-22

2. Mitapivat reprograms the RBC metabolome and improves anemia in a mouse model of hereditary spherocytosis;JCI Insight;2023-10-23

3. Targeting mitochondrial impairment for the treatment of cardiovascular diseases: From hypertension to ischemia-reperfusion injury, searching for new pharmacological targets;Biochemical Pharmacology;2023-02

4. Cellular Redox Metabolism Is Modulated by the Distinct Localization of Cyclic Nucleotide Phosphodiesterase 5A Isoforms;International Journal of Molecular Sciences;2022-08-02

5. Evidence for the Benefits of Melatonin in Cardiovascular Disease;Frontiers in Cardiovascular Medicine;2022-06-20